NYSE:A

Stock Analysis Report

Executive Summary

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.

Snowflake

Fundamentals

Outstanding track record with flawless balance sheet.


Similar Companies

Share Price & News

How has Agilent Technologies's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0.1%

A

-1.8%

US Life Sciences

1.0%

US Market


1 Year Return

14.6%

A

13.5%

US Life Sciences

6.7%

US Market

Return vs Industry: A exceeded the US Life Sciences industry which returned 13.5% over the past year.

Return vs Market: A exceeded the US Market which returned 6.7% over the past year.


Share holder returns

AIndustryMarket
7 Day0.1%-1.8%1.0%
30 Day-3.5%-4.6%-1.8%
90 Day7.5%-4.1%-1.8%
1 Year15.6%14.6%13.7%13.5%9.1%6.7%
3 Year71.2%66.5%79.2%77.8%46.1%36.6%
5 Year110.8%43.6%123.9%113.5%66.9%48.6%

Price Volatility Vs. Market

How volatile is Agilent Technologies's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Agilent Technologies undervalued based on future cash flows and its price relative to the stock market?

22.2x

Price to Earnings (PE) ratio


Intrinsic Value Based on Future Cash Flows

Undervalued: A ($75.18) is trading above our estimate of fair value ($63.16)

Significantly Undervalued: A is trading above our estimate of fair value.


Price Based on Earnings

PE vs Industry: A is good value based on its PE Ratio (22.2x) compared to the Life Sciences industry average (32.1x).

PE vs Market: A is poor value based on its PE Ratio (22.2x) compared to the US market (17.5x).


Price Based on Expected Growth

Low PEG Ratio: A's earnings are forecast to decline next year, so we can't calculate its PEG ratio.


Price Based on Value of Assets

PB vs Industry: A is overvalued based on its PB Ratio (4.9x) compared to the US Life Sciences industry average (4.5x).


Next Steps

Future Growth

How is Agilent Technologies expected to perform in the next 1 to 3 years based on estimates from 13 analysts?

-3.0%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

Earnings vs Savings Rate: A's earnings are forecast to decline over the next 3 years (-3% per year).

Earnings vs Market: A's earnings are forecast to decline over the next 3 years (-3% per year).

High Growth Earnings: A's earnings are forecast to decline over the next 3 years.

Revenue vs Market: A's revenue (6.5% per year) is forecast to grow slower than the US market (7.3% per year).

High Growth Revenue: A's revenue (6.5% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Estimates


Future Return on Equity

High Future ROE: A's Return on Equity is forecast to be high in 3 years time (22.4%)


Next Steps

Past Performance

How has Agilent Technologies performed over the past 5 years?

22.0%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: A's earnings have grown significantly by 22% per year over the past 5 years.

Accelerating Growth: A's earnings growth over the past year (259.7%) exceeds its 5-year average (22% per year).

Earnings vs Industry: A earnings growth over the past year (259.7%) exceeded the Life Sciences industry 45%.


Return on Equity

High ROE: A's Return on Equity (22.6%) is considered high.


Return on Assets

ROA vs Industry: A has a higher Return on Assets than the Life Sciences industry average last year.


Return on Capital Employed

ROCE Improving: A has significantly improved its Return on Capital Employed over the past 3 years.


Next Steps

Financial Health

How is Agilent Technologies's financial position?


Financial Position Analysis

Short Term Liabilities: A's short term assets ($3.5B) exceeds its short term liabilities ($1.6B)

Long Term Liabilities: A's short term assets (3.5B) exceeds its long term liabilities (2.3B)


Debt to Equity History and Analysis

Debt Level: A's debt to equity ratio (37.9%) is considered satisfactory

Reducing Debt: A's debt to equity ratio has reduced from 39.2% to 37.9% over the past 5 years.

Debt Coverage: A's debt is well covered by operating cash flow (60%).

Interest Coverage: A's interest payments on its debt are well covered by EBIT (32.6x coverage).


Balance Sheet

Inventory Level: A has a low level of unsold assets or inventory.

Debt Coverage by Assets: A's debt is covered by short term assets (assets are 1.922690x debt).


Next Steps

Dividend

What is Agilent Technologies's current dividend yield, its reliability and sustainability?

0.93%

Expected Dividend Yield


Dividend Yield vs Market

company0.9%marketbottom25%1.5%markettop25%3.8%industryaverage0.6%forecastin3Years0.9%

Current dividend yield vs market & industry


Dividend Yield and Payments Analysis

Notable Dividend: A's dividend (0.87%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.46%).

High Dividend: A's dividend (0.87%) is low compared to the top 25% of dividend payers in the US market (3.77%).

Stable Dividend: A has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: A's dividend payments have increased, but the company has only paid a dividend for 8 years.


Current Payout to Shareholders

Dividend Coverage: With its low payout ratio (18.9%), A's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: A's dividends in 3 years are forecast to be well covered by earnings (17.7% payout ratio).


Next Steps

Management

What is the CEO of Agilent Technologies's salary, the management and board of directors tenure and is there insider trading?

4.5yrs

Average management tenure


CEO

Mike McMullen (58yo)

4.6yrs

Tenure

US$11,708,230

Compensation

Mr. Michael R. McMullen, also known as Mike, has been the President of Agilent Technologies, Inc., since September 17, 2014 and Chief Executive Officer since March 18, 2015. Mr. McMullen has been a Directo ...


CEO Compensation Analysis

Compensation vs. Market: Mike's total compensation ($USD11.71M) is about average for companies of similar size in the US market ($USD11.20M).

Compensation vs Earnings: Mike's compensation has been consistent with company performance over the past year.


Management Age and Tenure

4.5yrs

Average Tenure

55.5yo

Average Age

Experienced Management: A's management team is considered experienced (4.5 years average tenure).


Board Age and Tenure

4.4yrs

Average Tenure

65yo

Average Age

Experienced Board: A's board of directors are considered experienced (4.4 years average tenure).


Insider Trading

Insider Buying: A insiders have only sold shares in the past 3 months.


Recent Insider Transactions

SellUS$314,25624 Sep 19
Heidi Fields
EntityIndividual
Role
Member of the Board of Directors
Director
Shares4,000
Max PriceUS$78.56
SellUS$283,85604 Sep 19
Heidi Fields
EntityIndividual
Role
Member of the Board of Directors
Director
Shares4,000
Max PriceUS$70.98
SellUS$226,71527 Mar 19
Paul Clark
EntityIndividual
Role
Member of the Board of Directors
Non-Executive Director
Shares2,823
Max PriceUS$80.31
SellUS$92,15708 Mar 19
Rodney Gonsalves
EntityIndividual
Role
Chief Accounting Officer
Chief Accounting Officer
Shares1,155
Max PriceUS$79.79
SellUS$311,80025 Feb 19
Mark Doak
EntityIndividual
Role
Senior Key Executive
Senior Vice President
Shares4,000
Max PriceUS$77.95
SellUS$106,59029 Nov 18
Rodney Gonsalves
EntityIndividual
Role
Chief Accounting Officer
Chief Accounting Officer
Shares1,500
Max PriceUS$71.06

Ownership Breakdown


Management Team

  • Darlene J. Solomon (60yo)

    CTO & Senior VP

    • Tenure: 16.1yrs
  • Rodney Gonsalves (53yo)

    Chief Accounting Officer

    • Tenure: 4.4yrs
  • Mike McMullen (58yo)

    CEO, President & Director

    • Tenure: 4.6yrs
    • Compensation: US$11.71m
  • Jacob Thaysen (44yo)

    Senior Vice President

    • Tenure: 0yrs
    • Compensation: US$3.02m
  • Michael Tang (45yo)

    Senior VP

    • Tenure: 3.8yrs
  • Eric Gerber

    Senior Vice President of Strategy & Corporate Development

    • Tenure: 0.9yrs
  • Dominique Grau (60yo)

    Senior Vice President of Human Resources

    • Tenure: 5.2yrs
    • Compensation: US$2.21m
  • Bob McMahon (50yo)

    Senior VP & CFO

    • Tenure: 1.1yrs
    • Compensation: US$6.58m
  • Mark Doak (64yo)

    Senior Vice President

    • Tenure: 5.1yrs
    • Compensation: US$3.32m
  • Ankur Dhingra

    Vice President of Investor Relations

    • Tenure: 0yrs

Board Members

  • Heidi Fields (64yo)

    Director

    • Tenure: 19.7yrs
    • Compensation: US$294.04k
  • Paul Clark (72yo)

    Non-Executive Director

    • Tenure: 13.4yrs
    • Compensation: US$319.04k
  • Tachi Yamada (73yo)

    Director

    • Tenure: 8.8yrs
    • Compensation: US$314.04k
  • George Scangos (71yo)

    Director

    • Tenure: 5.1yrs
    • Compensation: US$294.04k
  • Dow Wilson (60yo)

    Director

    • Tenure: 1.6yrs
    • Compensation: US$271.01k
  • Boon Hwee Koh (68yo)

    Non-Executive Chairman

    • Tenure: 2.6yrs
    • Compensation: US$449.04k
  • Dan Podolsky (66yo)

    Director

    • Tenure: 4.3yrs
    • Compensation: US$304.04k
  • Mike McMullen (58yo)

    CEO, President & Director

    • Tenure: 4.6yrs
    • Compensation: US$11.71m
  • Hans Bishop (55yo)

    Director

    • Tenure: 2.3yrs
    • Compensation: US$260.71k
  • Sue Rataj (62yo)

    Director

    • Tenure: 4.1yrs
    • Compensation: US$304.04k

Company Information

Agilent Technologies, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Agilent Technologies, Inc.
  • Ticker: A
  • Exchange: NYSE
  • Founded: 1999
  • Industry: Life Sciences Tools and Services
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$23.266b
  • Shares outstanding: 309.47m
  • Website: https://www.agilent.com

Number of Employees


Location

  • Agilent Technologies, Inc.
  • 5301 Stevens Creek Boulevard
  • Santa Clara
  • California
  • 95051
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
ANYSE (New York Stock Exchange)YesCommon StockUSUSDNov 1999
AG8DB (Deutsche Boerse AG)YesCommon StockDEEURNov 1999
A *BMV (Bolsa Mexicana de Valores)YesCommon StockMXMXNNov 1999
0HAVLSE (London Stock Exchange)YesCommon StockGBUSDNov 1999

Biography

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/14 23:31
End of Day Share Price2019/10/14 00:00
Earnings2019/07/31
Annual Earnings2018/10/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

© 2018 SIMPLY WALL STREET PTY LTD, COMMUNITY DESIGN 2845206, US DESIGN PATENT #29/544/281, EUROPEAN DESIGN REGISTRATION #2845206, STANDARD & POOR’S FINANCIAL SERVICES LLC. ALL RIGHTS RESERVED.

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Copyright © 2018, Standard & Poor’s Financial Services LLC. Reproduction of S&P Capital IQ in any form is prohibited except with the prior written permission of S&P. S&P does not guarantee the accuracy, adequacy, completeness or availability of any information and is not responsible for any errors or omissions, regardless of the cause or for the results obtained from the use of such information. S&P DISCLAIMS ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE. In no event shall S&P be liable for any direct, indirect, special or consequential damages, costs, expenses, legal fees, or losses (including lost income or lost profit and opportunity costs) in connection with subscriber’s or others’ use of S&P Capital IQ. (2018)